From IDRI CEO Stewart Parker Steps Down, Erik Iverson Steps Up:

bio-erik-iverson

bio-erik-iverson—

Erik Iverson

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Sponsored · Webinar
Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury (DILI) Early in Drug Discovery
In vitro assays that tackle the challenges of in vitro hepatotoxicity assessment
Eurofins Discovery

From Our Editors · Special Report
Xcelerating Life Sciences San Diego: Special Report
Learn what's fueling San Diego's biotech investment and partnership opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!